Bardin Hill Management Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-105,445
Closed -$19M 39
2017
Q3
$19M Buy
+105,445
New +$14.7M 3.28% 11

Bardin Hill Management Partners's KITE Position: Q4 2017 in Review

Bardin Hill Management Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 105,445 shares — an estimated $19M sold.

Bardin Hill Management Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $19M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Bardin Hill Management Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bardin Hill Management Partners sold 105,445 Kite Pharma, Inc. shares in Q4 2017, an estimated $19M.
  • Bardin Hill Management Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Bardin Hill Management Partners's Kite Pharma, Inc. position peaked at $19M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Bardin Hill Management Partners's 13F filing for Q4 2017, filed 14 Feb 2018.